G protein-coupled receptors mediate transmembrane signal transduction for a variety of hormones, neurotransmitters, chemokines, and synthetic ligands. It had been thought that a given receptor couples only to a single class of heterotrimeric G proteins to achieve signaling selectivity and specificity. As a model system of G proteincoupled receptors, ␤-adrenergic receptor (␤AR) was believed to activate exclusively a G s -adenylyl cyclase-cAMP-protein kinase A (PKA) signaling cascade. This doctrine, however, has been challenged by recent findings that, although seeming illogical, ␤ 2 AR dually couples to G s and G i proteins in rodent and canine hearts 1-3 (for review, see Reference 4). In this issue of Circulation Research, Kilts et al 5 present a solid study that provides additional evidence supporting a dual G protein coupling for ␤ 2 AR and extended the previous finding to several other G s -coupled receptors in human heart.
G s and G i Dichotomy
Early studies showed that stimulation of ␤ 1 AR, but not ␤ 2 AR, induces a relaxant effect, 6 ,7 a hallmark of cAMP-dependent cardiac modulation. Moreover, ␤ 2 AR-induced augmentations in intracellular Ca 2ϩ transient and contractility are apparently dissociated from cellular cAMP accumulation and PKA-mediated protein phosphorylation in rat ventricular myocytes, whereas the classic linear G s -adenylyl cyclase-cAMP-PKA signaling cascade is corroborated for ␤ 1 AR stimulation. 8 These findings provided the first clue that there are some substantial differences between ␤ 1 AR and ␤ 2 AR signaling pathways.
In search for answers to the anomalous behavior of cardiac ␤ 2 AR stimulation, recent studies have revealed dichotomous G protein coupling for native ␤ 2 AR under physiological conditions. Disrupting G i signaling by pertussis toxin (PTX)-mediated ribosylation enhances ␤ 2 AR-induced contractile response in rat ventricular myocytes 1 5 it is noteworthy that the G s and G i interaction is not necessarily confined to the cyclase level. 3, 11 Counterintuitively, promiscuous G protein coupling may enhance, rather than compromise, the receptor signaling specificity. This point is perhaps best exemplified by ␤AR subtype stimulation. In rodent and canine hearts, ␤ 1 AR stimulation increases phosphorylation of phospholamban, which accelerates Ca 2ϩ sequestration into the sarcoplasmic reticulum, resulting in accelerated cardiac relaxation, 4, 6, 8, 12 and increases phosphorylation of troponin I and C protein, 12 which reduces myofilament sensitivity to Ca 2ϩ . In contrast, ␤ 2 AR stimulation modulates specifically L-type Ca 2ϩ channels, bypassing the aforementioned intracellular regulatory proteins. 3, 6, 8, 12 In a direct approach involving on-cell patch-clamp recordings, it has been shown that ␤ 2 AR stimulation modulates single L-type Ca 2ϩ channel activity only in a local mode (agonist included in pipette solution) but not in a remote mode (agonist added to bathing solution outside the patch), whereas ␤ 1 AR stimulation does so in either mode. 13 G i activation is essential to the spatial localization and effector selectivity of ␤ 2 AR signal-ing, because inhibiting G i function with PTX permits a remote ␤ 2 AR effect on L-type Ca 2ϩ channels 13 and a robust increase in phospholamban phosphorylation as well as a markedly accelerated relaxation in response to ␤ 2 AR stimulation. 3 Equally appealing, G i activation may deliver G s -independent signals through G i␣ and G i␤␥ , further enriching receptor signaling diversity. For example, stimulation of the recombinant ␤ 2 AR transiently expressed in HEK 293 cells activates both G s and G i ; the latter increases the activity of mitogen-activated protein kinase, 14 which plays an important role in regulating chronic cellular processes such as cell growth and cell death.
In principle, the aforementioned interplay between G s and G i signals could be conducted by two types of receptors coupled to G s and G i , respectively. In contrast to the "two receptor, two G protein" system, the beauty of the "one receptor, two G protein" design is that it ensures a proportional activation of the dual G protein signals and affords a spatial and temporal colocalization and coordination of these signals. The delicate balance of G s and G i signaling in space and time might be crucial to normal cellular functions.
Pathophysiological Relevance
Programmed cell death or apoptosis has been recently implicated as a consequence of cardiac ischemic/reperfusion injury, contributing to the transition from cardiac hypertrophy to decompensatory heart failure. [15] [16] [17] In vivo and in vitro studies indicate that ␤ 1 AR and ␤ 2 AR exhibit distinctly different, even opposing, effects on cardiac myocyte apoptosis. In cultured adult rat cardiac myocytes, stimulation of ␤ 1 AR, but not ␤ 2 AR, induces myocyte apoptosis. 18 Using a ␤ 1 ␤ 2 AR double knockout mouse model in conjunction with adenoviral gene transfer, we have created pure ␤AR subtype experimental settings and found that ␤ 1 AR stimulation markedly induces myocyte apoptosis. In contrast, ␤ 2 AR stimulation activates concurrent apoptotic and survival signals mediated by G i and G s , respectively, with the G i -mediated survival effect predominant (Zhu W-Z, Zheng M, Kolbilka BK, Xiao R-P, unpublished data, 2000). Moreover, activation of ␤ 2 ARcoupled G i protects cardiac myocytes from a range of apoptotic assaults, including hypoxia or reactive oxygen species-induced apoptosis (Chesley A, Ohtani S, Asai T, Xiao R-P, Lunberg MS, Lakatta EG, Crow MT, unpublished data, 2000).
Chronic stimulation of these ␤AR subtypes in the heart also elicits strikingly different phenotypes in murine transgenic models. Overexpression of cardiac ␤ 1 AR by Ϸ5-to 46-fold induces cardiac hypertrophy, apoptosis, and fibrosis within a few weeks after birth and heart failure within several months. 19, 20 Ironically, overexpression of cardiac ␤ 2 AR by Ϸ100-to 200-fold does not induce hypertrophy or heart failure, [21] [22] [23] at least up to the age of 1 year. However, overwhelming expression of ␤ 2 AR (eg, Ϸ350-to 1000-fold) induces pathological phenotypes, 22, 23 perhaps caused by a mechanic and metabolic overload (markedly enhanced baseline adenylyl cyclase activity and cardiac contractility) due to spontaneous ␤ 2 AR activation. Whether the distinct phenotypes of ␤ 2 AR versus ␤ 1 AR mouse transgenic models are related to their different G protein coupling merits further investigations.
Although activation of ␤ 2 AR-coupled G i protects cardiac myocytes against apoptosis, an imbalance of ␤ 2 AR-initiated G s and G i signaling pathways may induce pathological consequences. Chronic heart failure in human and animal models is characterized by a diminished contractile response to ␤AR stimulation, 24 -29 accompanied by a selective downregulation of ␤ 1 AR (higher ␤ 2 /␤ 1 ratio) 24 -27 and an increase in the amount or activity of G i proteins. [27] [28] [29] [30] [31] In light of the G s and G i dichotomy, the upregulation of G i may participate in the defect of ␤AR inotropic effect in the decompensated failing heart. This idea is supported by recent observations that PTX treatment restores the diminished ␤AR inotropic response in a rat myocardial infarction heart failure model 32 and in myocytes from failing human hearts. 33 On the basis of these findings, we speculate that the selective downregulation of ␤ 1 AR and the upregulation of ␤ 2 AR/G i signaling in functionally compensated hypertrophic heart or early stage of heart failure may represent a cardiac protective mechanism (eg, against myocyte apoptosis), which slows the progression of cardiomyopathy and contractile dysfunction. However, exaggerated ␤ 2 AR/G i signaling may blunt G smediated contractile support, contributing to the phenotype of decompensated heart failure.
Therapeutic Implications
It has been highly controversial as to whether enhancing ␤AR signaling is beneficial or deleterious for the failing heart. The prevalent view is that chronically increasing nonselective ␤AR stimulation is toxic to the heart, because there is an inverse relationship between the plasma level of norepinephrine and the survival of patients with heart failure 34 and because ␤AR blockade (eg, by ␤ 1 AR antagonists bisoprolol and metoprolol or a nonselective ␤AR blocker carvedilol) reduces both the morbidity and mortality in patients with heart failure. 35 However, the discovery of a new paradigm of ␤ 2 AR signaling (ie, the dual G protein coupling), the opposing effects of stimulation of these ␤AR subtypes on cardiomyocyte apoptosis, and the distinct phenotypes of cardiacspecific overexpression of ␤ 1 AR versus ␤ 2 AR underscore the necessity and importance of distinguishing ␤ 2 AR signaling from that of ␤ 1 AR in terms of their cardiac functional roles and therapeutic implications.
In our opinion, selectively enhancing ␤ 2 AR signaling may provide a novel therapeutic strategy in the prevention and treatment of chronic heart failure. Indeed, crossing transgenic mice overexpressing cardiac ␤ 2 AR at appropriate levels (eg, 30-fold) with transgenic mice overexpressing G q␣ not only improves the cardiac performance but also reverses hypertrophy in the G q␣ overexpression heart failure model, 22 although extremely high levels of ␤ 2 AR overexpression (eg, Ϸ350-to 1000-fold) fail to rescue the genetic mouse heart failure model. 22 Additionally, the beneficial effect of ␤ 2 AR stimulation in the context of heart failure is clearly supported by the analysis of polymorphisms of ␤ 2 AR in chronic heart failure patients. The likelihood of earlier aggressive intervention or cardiac transplantation is significantly greater in heart failure patients with Ile164 polymorphism (a Thr to Ile switch at amino acid 164 with reduced ␤ 2 AR signaling efficacy) relative to patients without the ␤ 2 AR variant. 36 
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In summary, coupling of one receptor to more than one class of G proteins may represent a common property of many G s -coupled receptors, rather than a unique quality of ␤ 2 AR. The additional G i coupling not only confers spatial and temporal control of G s -stimulated signals, enhancing the receptor signaling specificity, but also enriches signaling diversity by delivering G s -independent signals. The discovery of the G s and G i dichotomy reshapes our current understanding of receptor-G protein interactions in physiological systems. An imbalance of the concurrent G s and G i signals may have important pathophysiological relevance and clinic implications.
